|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
08037 CH BIOTECH SER
Nominal 
1.070 +0.020 (+1.905%) | 2025/06 - Interim HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | |
| Net Cash from / (used in) Operating Activities | -- | (151,890) | 191,722 | 482,748 | 40,505 |
| Net Cash from / (used in) Investing Activities | -- | (47,766) | (54,428) | (256,311) | (8,124) |
| Net Cash from / (used in) Financing Activities | -- | 147,806 | (155,799) | (281,959) | (266,611) |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (51,850) | (18,505) | (55,522) | (234,230) |
| Cash & Cash Equivalents at beginning of period | -- | 72,087 | 92,770 | 150,554 | 384,539 |
| Effect of Foreign Exchange Rate Changes | -- | (1,324) | (2,178) | (2,262) | 245 |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 18,913 | 72,087 | 92,770 | 150,554 |
| Remarks: | Real time quote last updated: 11/09/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD -32,006 |
| %Change | -59.951% |
| EPS / (LPS) | HKD -0.033 |
| NBV Per Share ($) | HKD 0.245 |